Clinical research in older adults with hematologic malignancies: Opportunities for alignment in the Veterans Affairs

被引：0
作者：
Graf, Solomon A. [1 ,2 ,3 ]
Samples, Laura S. [4 ]
Keating, Tamarind M. [1 ]
Garcia, Jose M. [1 ,5 ]
机构：
[1] VAPSHCS, 1660 South Columbian Way,S-111-ONC, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[4] Univ Washington, Sch Med, Dept Med, Div Internal Med, Seattle, WA 98195 USA
[5] Univ Washington, Sch Med, Dept Med, VAPSHCS Geriatr Res & Educ Clin Ctr GRECC,Div Ger, Seattle, WA 98195 USA
来源：
SEMINARS IN ONCOLOGY | 2019年 / 46卷 / 4-5期
关键词：
Hematologic malignancies; Veterans Affairs; Geriatric; Clinical research; HEMATOPOIETIC-CELL TRANSPLANTATION; ASSESSMENT PREDICTS SURVIVAL; GERIATRIC ASSESSMENT; CANCER INCIDENCE; RISK-ASSESSMENT; UNITED-STATES; CHEMOTHERAPY; TOXICITIES; OUTCOMES; ALCOHOL;
D O I：
10.1053/j.seminoncol.2019.09.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Management of hematologic malignancies in older patients is complex and, with recent and anticipated trends in demographics, increasingly common. As a large, nationally integrated medical system the Veterans Affairs has the potential to lead in research to benefit these patients. In this review we describe the evolving treatment paradigms of hematologic malignancies and how they are best fit with older patients through comprehensive evaluation of key vulnerabilities. We also discuss optimization of supportive care and navigation services to target identified risks and challenges aimed at ameliorating the patient's burden of cancer and treatment. Lastly, we discuss opportunities in design of prospective clinical trials to better align with real-world cases, thereby expanding enrollment of and applicability to older patients with hematologic malignancies. Published by Elsevier Inc.
引用
收藏
页码：341 / 345
页数：5
相关论文
共 32 条
  • [1] Frailty and the management of hematologic malignancies
    Abel, Gregory A.
    Klepin, Heidi D.
    [J]. BLOOD, 2018, 131 (05) : 515 - 524
  • [2] Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
    Ali, Sumbul
    Garcia, Jose M.
    [J]. GERONTOLOGY, 2014, 60 (04) : 294 - 305
  • [3] Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
    Barr, Paul M.
    Brown, Jennifer R.
    Hillmen, Peter
    O'Brien, Susan
    Barrientos, Jacqueline C.
    Reddy, Nishitha M.
    Coutre, Steven
    Mulligan, Stephen P.
    Jaeger, Ulrich
    Furman, Richard R.
    Cymbalista, Florence
    Montillo, Marco
    Dearden, Claire
    Robak, Tadeusz
    Moreno, Carol
    Pagel, John M.
    Burger, Jan A.
    Suzuki, Samuel
    Sukbuntherng, Juthamas
    Cole, George
    James, Danelle F.
    Byrd, John C.
    [J]. BLOOD, 2017, 129 (19) : 2612 - 2615
  • [4] Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
    Bower, H.
    Andersson, T. M-L
    Bjorkholm, M.
    Dickman, P. W.
    Lambert, P. C.
    Derolf, A. R.
    [J]. BLOOD CANCER JOURNAL, 2016, 6 : e390 - e390
  • [5] Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
    Decoster, L.
    Van Puyvelde, K.
    Mohile, S.
    Wedding, U.
    Basso, U.
    Colloca, G.
    Rostoft, S.
    Overcash, J.
    Wildiers, H.
    Steer, C.
    Kimmick, G.
    Kanesvaran, R.
    Luciani, A.
    Terret, C.
    Hurria, A.
    Kenis, C.
    Audisio, R.
    Extermann, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (02) : 288 - 300
  • [6] Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws
    Dusetzina, Stacie B.
    Huskamp, Haiden A.
    Winn, Aaron N.
    Basch, Ethan
    Keating, Nancy L.
    [J]. JAMA ONCOLOGY, 2018, 4 (06)
  • [7] Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
    Extermann, M
    Aapro, M
    Bernabei, RB
    Cohen, HJ
    Droz, JP
    Lichtman, S
    Mor, V
    Monfardini, S
    Repetto, L
    Sorbye, L
    Topinkova, E
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 55 (03) : 241 - 252
  • [8] Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score
    Extermann, Martine
    Boler, Ivette
    Reich, Richard R.
    Lyman, Gary H.
    Brown, Richard H.
    DeFelice, Joseph
    Levine, Richard M.
    Lubiner, Eric T.
    Reyes, Pablo
    Schreiber, Frederic J., III
    Balducci, Lodovico
    [J]. CANCER, 2012, 118 (13) : 3377 - 3386
  • [9] Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma
    Graf, Solomon A.
    Vaughn, Jennifer E.
    Chauncey, Thomas R.
    Storer, Barry E.
    Gopal, Ajay K.
    Holmberg, Leona A.
    McCune, Jeannine S.
    Bensinger, William I.
    Maloney, David G.
    Press, Oliver W.
    Storb, Rainer
    Sorror, Mohamed L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1582 - 1587
  • [10] Hallek Michael, 2009, Hematology Am Soc Hematol Educ Program, P440, DOI 10.1182/asheducation-2009.1.440
1234